Targeting Energy Protection as a Novel Strategy to Disclose Di'ao Xinxuekang against the Cardiotoxicity Caused by Doxorubicin

• Published in: International journal of molecular sciences Vol. 24; no. 2; p. 897
• Main Authors: Wang, Tao, Yuan, Chuqiao, Liu, Jia, Deng, Liangyan, Li, Wei, He, Junling, Liu, Honglin, Qu, Liping, Wu, Jianming, Zou, Wenjun
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 04.01.2023; MDPI
• Subjects: Angina pectoris; Animals; Apoptosis; Autophagy; Cancer; Cardiac function; Cardiomyopathies - metabolism; Cardiotoxicity; Cardiotoxicity - drug therapy; Cardiotoxicity - etiology; Cardiotoxicity - prevention & control; Cardiovascular disease; Cells; Congestive heart failure; Doxorubicin; Doxorubicin - toxicity; Drug dosages; Energy; Energy metabolism; Enzymes; Fatty acids; Ferroptosis; Gene expression; Heart failure; Inflammation; Ischemia; Kinases; Metabolic disorders; Metabolites; Mice; Mitochondria; mitochondrion; Myocytes, Cardiac - metabolism; Oxidative Stress; Physiology; Rats; Signal Transduction; Tumors; Xinxuekang; cardiotoxicity; doxorubicin; energy metabolism; Xinxuekang; mitochondrion
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms24020897

Doxorubicin (DOX) can induce myocardial energy metabolism disorder and further worsen heart failure. "Energy protection" is proposed as a new cardiac protection strategy. Previous studies have found that Di'ao Xinxuekang (DXXK) can improve doxorubicin-induced cardiotoxicity in mice by inhibiting ferroptosis. However, there are very few studies associating DXXK and energy protection. This study aims to explore the "energy protection" effect of DXXK on cardiotoxicity induced by DOX. A DOX-induced cardiotoxicity model established in rats and H9c2 cells are used to analyze the therapeutic effects of DXXK on serum indexes, cardiac function indexes and cardiac histopathology. The metabonomic methods were used to explore the potential mechanism of DXXK in treating DOX-induced cardiotoxicity. In addition, we also observed the mitochondrial- and autophagy-related indicators of myocardial cells and the mRNA expression level of the core target regulating energy-metabolism-related pathways. Our results indicated that DXXK can improve cardiac function, reduce myocardial enzymes and alleviate the histological damage of heart tissue caused by DOX. In addition, DXXK can improve mitochondrial damage induced by DOX and inhibit excessive autophagy. Metabonomics analysis showed that DOX can significantly affects the pathways related to energy metabolism of myocardial cells, which are involved in the therapeutic mechanism of DXXK. In conclusion, DXXK can treat DOX-induced cardiotoxicity through the AMPK-mediated energy protection pathway.